Publications

Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

 83
Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

Tags:

Previous Article

Fibroblast growth factor receptor (FGFR) rearrangements in cancer!

Next Article

Mechanism of lipid-dependent cold sensitivity in a model ion channel

Related Posts

Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis

Lack of PCK1 in hepatic stellate cells causes liver fib...

 35

Multi-omics analysis of SFTS virus infection in Rhipicephalus microplus cells reveals antiviral tick factors

Multi-omics analysis of SFTS virus infection in Rhipice...

 61

Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis

Extracellular matrix mediates circulating tumor cell cl...

 34